25 XP   0   0   10

Oxurion NV
Buy, Hold or Sell?

Let's analyse Oxurion together

PenkeI guess you are interested in Oxurion NV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Oxurion NV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Oxurion NV

I send you an email if I find something interesting about Oxurion NV.

Quick analysis of Oxurion (30 sec.)










What can you expect buying and holding a share of Oxurion? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.00
Expected worth in 1 year
€0.00
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
€0.00
Return On Investment
-1,882.3%

For what price can you sell your share?

Current Price per Share
€0.00
Expected price per share
€0.0001 - €0.0002
How sure are you?
50%

1. Valuation of Oxurion (5 min.)




Live pricePrice per Share (EOD)

€0.00

Intrinsic Value Per Share

€-0.07 - €0.00

Total Value Per Share

€-0.07 - €0.00

2. Growth of Oxurion (5 min.)




Is Oxurion growing?

Current yearPrevious yearGrowGrow %
How rich?-$4.9m-$1.1m-$3.7m-75.8%

How much money is Oxurion making?

Current yearPrevious yearGrowGrow %
Making money-$33.9m-$31.2m-$2.7m-8.0%
Net Profit Margin-5,325.2%-2,584.9%--

How much money comes from the company's main activities?

3. Financial Health of Oxurion (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#923 / 1010

Most Revenue
#530 / 1010

Most Profit
#820 / 1010

Most Efficient
#910 / 1010

What can you expect buying and holding a share of Oxurion? (5 min.)

Welcome investor! Oxurion's management wants to use your money to grow the business. In return you get a share of Oxurion.

What can you expect buying and holding a share of Oxurion?

First you should know what it really means to hold a share of Oxurion. And how you can make/lose money.

Speculation

The Price per Share of Oxurion is €0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Oxurion.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Oxurion, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.00. Based on the TTM, the Book Value Change Per Share is €0.00 per quarter. Based on the YOY, the Book Value Change Per Share is €0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Oxurion.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.00-4,592.0%0.00-4,592.0%0.00-4,225.8%-0.01-5,192.9%0.00-4,047.5%
Usd Book Value Change Per Share0.00-503.6%0.00-503.6%0.00-3,790.7%0.00-3,998.3%0.00-3,370.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-503.6%0.00-503.6%0.00-3,790.7%0.00-3,998.3%0.00-3,370.3%
Usd Price Per Share0.02-0.02-1.94-2.35-5.04-
Price to Earnings Ratio-4.43--4.43--459.91--450.60-253.31-
Price-to-Total Gains Ratio-40.38--40.38--512.70--518.55-134.89-
Price to Book Ratio-30.61--30.61--12,102.94--2,143.56--939.91-
Price-to-Total Gains Ratio-40.38--40.38--512.70--518.55-134.89-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.00010702
Number of shares9344047
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (9344047 shares)-4,705.87-37,359.89
Gains per Year (9344047 shares)-18,823.49-149,439.54
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-18823-188330-149440-149450
20-37647-376560-298879-298890
30-56470-564790-448319-448330
40-75294-753020-597758-597770
50-94117-941250-747198-747210
60-112941-1129480-896637-896650
70-131764-1317710-1046077-1046090
80-150588-1505940-1195516-1195530
90-169411-1694170-1344956-1344970
100-188235-1882400-1494395-1494410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%4.013.00.023.5%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%8.09.00.047.1%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.017.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%8.09.00.047.1%

Fundamentals of Oxurion

About Oxurion NV

Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist, which is in Phase II clinical trials for the treatment of DME. Oxurion NV has collaboration agreements with Bicycle Therapeutics and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

Fundamental data was last updated by Penke on 2024-04-09 21:02:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Oxurion NV.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Oxurion earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Oxurion to the Biotechnology industry mean.
  • A Net Profit Margin of -5,325.2% means that €-53.25 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oxurion NV:

  • The MRQ is -5,325.2%. The company is making a huge loss. -2
  • The TTM is -5,325.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-5,325.2%TTM-5,325.2%0.0%
TTM-5,325.2%YOY-2,584.9%-2,740.3%
TTM-5,325.2%5Y-2,260.1%-3,065.1%
5Y-2,260.1%10Y-1,258.4%-1,001.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,325.2%-207.2%-5,118.0%
TTM-5,325.2%-216.8%-5,108.4%
YOY-2,584.9%-282.3%-2,302.6%
5Y-2,260.1%-436.8%-1,823.3%
10Y-1,258.4%-597.3%-661.1%
1.1.2. Return on Assets

Shows how efficient Oxurion is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Oxurion to the Biotechnology industry mean.
  • -264.2% Return on Assets means that Oxurion generated €-2.64 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oxurion NV:

  • The MRQ is -264.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -264.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-264.2%TTM-264.2%0.0%
TTM-264.2%YOY-154.5%-109.7%
TTM-264.2%5Y-122.8%-141.4%
5Y-122.8%10Y-68.3%-54.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-264.2%-13.3%-250.9%
TTM-264.2%-12.8%-251.4%
YOY-154.5%-11.6%-142.9%
5Y-122.8%-13.8%-109.0%
10Y-68.3%-15.6%-52.7%
1.1.3. Return on Equity

Shows how efficient Oxurion is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Oxurion to the Biotechnology industry mean.
  • 0.0% Return on Equity means Oxurion generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oxurion NV:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-49.1%+49.1%
5Y-49.1%10Y-32.0%-17.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM--16.1%+16.1%
YOY--14.9%+14.9%
5Y-49.1%-19.3%-29.8%
10Y-32.0%-20.1%-11.9%

1.2. Operating Efficiency of Oxurion NV.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Oxurion is operating .

  • Measures how much profit Oxurion makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Oxurion to the Biotechnology industry mean.
  • An Operating Margin of -3,828.4% means the company generated €-38.28  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oxurion NV:

  • The MRQ is -3,828.4%. The company is operating very inefficient. -2
  • The TTM is -3,828.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-3,828.4%TTM-3,828.4%0.0%
TTM-3,828.4%YOY-2,543.3%-1,285.1%
TTM-3,828.4%5Y-1,900.4%-1,928.0%
5Y-1,900.4%10Y-1,078.2%-822.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,828.4%-298.0%-3,530.4%
TTM-3,828.4%-238.5%-3,589.9%
YOY-2,543.3%-288.4%-2,254.9%
5Y-1,900.4%-486.2%-1,414.2%
10Y-1,078.2%-628.4%-449.8%
1.2.2. Operating Ratio

Measures how efficient Oxurion is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 39.28 means that the operating costs are €39.28 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Oxurion NV:

  • The MRQ is 39.284. The company is inefficient in keeping operating costs low. -1
  • The TTM is 39.284. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ39.284TTM39.2840.000
TTM39.284YOY26.433+12.851
TTM39.2845Y20.004+19.280
5Y20.00410Y11.434+8.569
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ39.2843.235+36.049
TTM39.2843.310+35.974
YOY26.4333.838+22.595
5Y20.0045.679+14.325
10Y11.4347.823+3.611

1.3. Liquidity of Oxurion NV.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Oxurion is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.58 means the company has €0.58 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Oxurion NV:

  • The MRQ is 0.575. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.575. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.575TTM0.5750.000
TTM0.575YOY1.229-0.653
TTM0.5755Y4.069-3.493
5Y4.06910Y7.567-3.498
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5753.863-3.288
TTM0.5754.169-3.594
YOY1.2295.337-4.108
5Y4.0696.122-2.053
10Y7.5676.434+1.133
1.3.2. Quick Ratio

Measures if Oxurion is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Oxurion to the Biotechnology industry mean.
  • A Quick Ratio of 0.37 means the company can pay off €0.37 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oxurion NV:

  • The MRQ is 0.365. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.365. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.365TTM0.3650.000
TTM0.365YOY1.027-0.662
TTM0.3655Y4.484-4.119
5Y4.48410Y7.826-3.341
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3653.504-3.139
TTM0.3653.991-3.626
YOY1.0275.371-4.344
5Y4.4846.088-1.604
10Y7.8266.395+1.431

1.4. Solvency of Oxurion NV.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Oxurion assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Oxurion to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.38 means that Oxurion assets are financed with 138.2% credit (debt) and the remaining percentage (100% - 138.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Oxurion NV:

  • The MRQ is 1.382. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.382. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.382TTM1.3820.000
TTM1.382YOY1.059+0.323
TTM1.3825Y0.595+0.787
5Y0.59510Y0.334+0.261
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3820.339+1.043
TTM1.3820.337+1.045
YOY1.0590.271+0.788
5Y0.5950.368+0.227
10Y0.3340.388-0.054
1.4.2. Debt to Equity Ratio

Measures if Oxurion is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Oxurion to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oxurion NV:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.136-0.136
5Y0.13610Y0.108+0.028
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.392-0.392
TTM-0.403-0.403
YOY-0.335-0.335
5Y0.1360.427-0.291
10Y0.1080.461-0.353

2. Market Valuation of Oxurion NV

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Oxurion generates.

  • Above 15 is considered overpriced but always compare Oxurion to the Biotechnology industry mean.
  • A PE ratio of -4.43 means the investor is paying €-4.43 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oxurion NV:

  • The EOD is -0.023. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.428. Based on the earnings, the company is expensive. -2
  • The TTM is -4.428. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.023MRQ-4.428+4.405
MRQ-4.428TTM-4.4280.000
TTM-4.428YOY-459.910+455.482
TTM-4.4285Y-450.598+446.170
5Y-450.59810Y253.306-703.904
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.023-2.300+2.277
MRQ-4.428-2.656-1.772
TTM-4.428-2.718-1.710
YOY-459.910-4.145-455.765
5Y-450.598-6.258-444.340
10Y253.306-6.315+259.621
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Oxurion NV:

  • The EOD is -0.037. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.989. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.989. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.037MRQ-6.989+6.952
MRQ-6.989TTM-6.9890.000
TTM-6.989YOY-493.252+486.263
TTM-6.9895Y-548.937+541.948
5Y-548.93710Y277.231-826.168
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.037-2.974+2.937
MRQ-6.989-3.306-3.683
TTM-6.989-3.508-3.481
YOY-493.252-5.613-487.639
5Y-548.937-8.378-540.559
10Y277.231-8.873+286.104
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Oxurion is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -30.61 means the investor is paying €-30.61 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Oxurion NV:

  • The EOD is -0.161. Based on the equity, the company is expensive. -2
  • The MRQ is -30.614. Based on the equity, the company is expensive. -2
  • The TTM is -30.614. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.161MRQ-30.614+30.453
MRQ-30.614TTM-30.6140.000
TTM-30.614YOY-12,102.935+12,072.322
TTM-30.6145Y-2,143.563+2,112.949
5Y-2,143.56310Y-939.912-1,203.651
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.1611.914-2.075
MRQ-30.6142.116-32.730
TTM-30.6142.097-32.711
YOY-12,102.9352.881-12,105.816
5Y-2,143.5633.550-2,147.113
10Y-939.9123.936-943.848
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Oxurion NV compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.0000%-0.004+653%-0.004+694%-0.003+569%
Book Value Per Share---0.001-0.0010%0.000-76%0.005-113%0.014-104%
Current Ratio--0.5750.5750%1.229-53%4.069-86%7.567-92%
Debt To Asset Ratio--1.3821.3820%1.059+31%0.595+132%0.334+314%
Debt To Equity Ratio----0%-0%0.136-100%0.108-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.004-0.0040%-0.004-8%-0.005+13%-0.004-12%
Free Cash Flow Per Share---0.003-0.0030%-0.004+35%-0.004+37%-0.003-6%
Free Cash Flow To Equity Per Share---0.001-0.0010%-0.002+138%-0.003+252%-0.002+135%
Gross Profit Margin--1.0281.0280%1.044-1%1.074-4%1.0290%
Intrinsic Value_10Y_max--0.001--------
Intrinsic Value_10Y_min---0.073--------
Intrinsic Value_1Y_max---0.002--------
Intrinsic Value_1Y_min---0.005--------
Intrinsic Value_3Y_max---0.004--------
Intrinsic Value_3Y_min---0.016--------
Intrinsic Value_5Y_max---0.005--------
Intrinsic Value_5Y_min---0.031--------
Market Cap738439.014-18900%140303412.736140303412.7360%13410052501.504-99%16186583195.648-99%34792292602.470-100%
Net Profit Margin---53.252-53.2520%-25.849-51%-22.601-58%-12.584-76%
Operating Margin---38.284-38.2840%-25.433-34%-19.004-50%-10.782-72%
Operating Ratio--39.28439.2840%26.433+49%20.004+96%11.434+244%
Pb Ratio-0.161+99%-30.614-30.6140%-12102.935+39434%-2143.563+6902%-939.912+2970%
Pe Ratio-0.023+99%-4.428-4.4280%-459.910+10286%-450.598+10076%253.306-102%
Price Per Share0.000-18900%0.0190.0190%1.816-99%2.192-99%4.712-100%
Price To Free Cash Flow Ratio-0.037+99%-6.989-6.9890%-493.252+6958%-548.937+7754%277.231-103%
Price To Total Gains Ratio-0.213+99%-40.375-40.3750%-512.695+1170%-518.546+1184%134.891-130%
Quick Ratio--0.3650.3650%1.027-64%4.484-92%7.826-95%
Return On Assets---2.642-2.6420%-1.545-42%-1.228-54%-0.683-74%
Return On Equity----0%-0%-0.4910%-0.3200%
Total Gains Per Share--0.0000.0000%-0.004+653%-0.004+694%-0.003+569%
Usd Book Value---4904726.600-4904726.6000%-1185781.600-76%38093340.920-113%113225875.760-104%
Usd Book Value Change Per Share---0.001-0.0010%-0.004+653%-0.004+694%-0.003+569%
Usd Book Value Per Share---0.001-0.0010%0.000-76%0.005-113%0.015-104%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.005-0.0050%-0.004-8%-0.005+13%-0.004-12%
Usd Free Cash Flow---21484265.000-21484265.0000%-29095527.400+35%-29328188.880+37%-20115693.240-6%
Usd Free Cash Flow Per Share---0.003-0.0030%-0.004+35%-0.004+37%-0.003-6%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%-0.002+138%-0.003+252%-0.002+135%
Usd Market Cap790277.433-18900%150152712.310150152712.3100%14351438187.110-99%17322881335.983-99%37234711543.164-100%
Usd Price Per Share0.000-18900%0.0200.0200%1.943-99%2.346-99%5.042-100%
Usd Profit---33909287.000-33909287.0000%-31204891.600-8%-38411832.440+13%-29921186.700-12%
Usd Revenue--636769.000636769.0000%1207185.600-47%2796860.466-77%17870306.513-96%
Usd Total Gains Per Share---0.001-0.0010%-0.004+653%-0.004+694%-0.003+569%
 EOD+2 -6MRQTTM+0 -0YOY+11 -215Y+15 -1810Y+10 -23

3.2. Fundamental Score

Let's check the fundamental score of Oxurion NV based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.023
Price to Book Ratio (EOD)Between0-1-0.161
Net Profit Margin (MRQ)Greater than0-53.252
Operating Margin (MRQ)Greater than0-38.284
Quick Ratio (MRQ)Greater than10.365
Current Ratio (MRQ)Greater than10.575
Debt to Asset Ratio (MRQ)Less than11.382
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.642
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Oxurion NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.889
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Accumulated Other Comprehensive Income  -10,120-2,617-12,7375,565-7,1721,550-5,6228,7503,128
Net Working Capital  81,535-34,90946,626-27,26519,361-16,8652,496-7,739-5,243



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets11,993
Total Liabilities16,576
Total Stockholder Equity-4,583
 As reported
Total Liabilities 16,576
Total Stockholder Equity+ -4,583
Total Assets = 11,993

Assets

Total Assets11,993
Total Current Assets7,106
Long-term Assets4,887
Total Current Assets
Cash And Cash Equivalents 3,496
Short-term Investments 95
Net Receivables 825
Inventory 5
Other Current Assets 2,685
Total Current Assets  (as reported)7,106
Total Current Assets  (calculated)7,106
+/-0
Long-term Assets
Property Plant Equipment 1,062
Long-term Assets Other 3,825
Long-term Assets  (as reported)4,887
Long-term Assets  (calculated)4,887
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities12,349
Long-term Liabilities4,227
Total Stockholder Equity-4,583
Total Current Liabilities
Short-term Debt 3,948
Short Long Term Debt 3,809
Accounts payable 5,040
Other Current Liabilities 3,361
Total Current Liabilities  (as reported)12,349
Total Current Liabilities  (calculated)16,158
+/- 3,809
Long-term Liabilities
Long term Debt 3,235
Capital Lease Obligations 972
Long-term Liabilities  (as reported)4,227
Long-term Liabilities  (calculated)4,207
+/- 20
Total Stockholder Equity
Common Stock65,443
Retained Earnings -73,404
Accumulated Other Comprehensive Income 3,128
Other Stockholders Equity 250
Total Stockholder Equity (as reported)-4,583
Total Stockholder Equity (calculated)-4,583
+/-0
Other
Capital Stock65,443
Cash and Short Term Investments 3,591
Common Stock Shares Outstanding 85,020
Liabilities and Stockholders Equity 11,993
Net Debt 4,520
Net Invested Capital 2,461
Net Working Capital -5,243
Property Plant and Equipment Gross 12,038
Short Long Term Debt Total 8,016



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
> Total Assets 
37,334
51,997
67,203
101,219
142,937
129,089
239,171
271,154
220,714
178,946
121,636
150,437
114,864
65,030
34,284
18,876
11,993
11,99318,87634,28465,030114,864150,437121,636178,946220,714271,154239,171129,089142,937101,21967,20351,99737,334
   > Total Current Assets 
34,218
48,354
61,448
80,108
113,477
87,784
159,751
191,634
149,168
116,693
91,439
124,283
91,089
57,015
27,054
13,409
7,106
7,10613,40927,05457,01591,089124,28391,439116,693149,168191,634159,75187,784113,47780,10861,44848,35434,218
       Cash And Cash Equivalents 
32,043
40,111
30,356
75,929
85,866
57,548
139,398
164,570
123,223
93,341
58,251
56,175
64,652
42,492
24,511
9,740
3,496
3,4969,74024,51142,49264,65256,17558,25193,341123,223164,570139,39857,54885,86675,92930,35640,11132,043
       Short-term Investments 
718
6,710
28,565
742
23,289
22,831
8,833
7,791
3,853
8,044
21,817
49,555
20,475
10,444
288
247
95
9524728810,44420,47549,55521,8178,0443,8537,7918,83322,83123,28974228,5656,710718
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
7,535
5,867
2,012
2,293
1,410
974
825
8259741,4102,2932,0125,8677,5350000000000
       Other Current Assets 
1,457
1,533
2,527
3,437
4,322
7,405
11,520
16,068
18,509
11,341
8,867
16,349
2,914
1,766
760
2,388
2,685
2,6852,3887601,7662,91416,3498,86711,34118,50916,06811,5207,4054,3223,4372,5271,5331,457
   > Long-term Assets 
3,116
3,643
5,755
21,111
29,460
41,305
79,420
79,520
71,546
62,253
30,197
26,154
23,775
8,015
7,230
5,467
4,887
4,8875,4677,2308,01523,77526,15430,19762,25371,54679,52079,42041,30529,46021,1115,7553,6433,116
       Property Plant Equipment 
530
1,057
1,004
1,042
894
1,492
2,699
3,634
2,911
2,088
1,743
991
614
2,552
1,299
372
1,062
1,0623721,2992,5526149911,7432,0882,9113,6342,6991,4928941,0421,0041,057530
       Goodwill 
2,586
2,586
2,586
2,586
2,586
0
2,586
2,586
2,586
2,586
0
0
0
0
0
0
0
00000002,5862,5862,5862,58602,5862,5862,5862,5862,586
       Intangible Assets 
0
0
2,092
17,357
25,832
0
72,338
69,209
62,388
55,699
25,902
23,603
20,450
1,982
2,127
1,000
0
01,0002,1271,98220,45023,60325,90255,69962,38869,20972,338025,83217,3572,09200
       Other Assets 
0
0
0
0
0
0
0
0
0
0
2,552
1,560
2,711
3,481
3,804
4,095
0
04,0953,8043,4812,7111,5602,5520000000000
> Total Liabilities 
2,056
3,562
4,810
7,501
4,747
11,060
11,205
12,382
12,702
8,931
11,777
17,080
9,554
11,724
9,236
19,984
16,576
16,57619,9849,23611,7249,55417,08011,7778,93112,70212,38211,20511,0604,7477,5014,8103,5622,056
   > Total Current Liabilities 
2,027
3,601
4,810
7,501
4,747
11,060
11,205
12,382
12,702
8,931
11,777
17,080
9,554
10,389
7,693
10,913
12,349
12,34910,9137,69310,3899,55417,08011,7778,93112,70212,38211,20511,0604,7477,5014,8103,6012,027
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
898
649
3,622
3,948
3,9483,6226498980000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,401
3,809
3,8093,401000000000000000
       Accounts payable 
1,785
0
0
6,688
4,034
9,336
9,303
10,352
7,369
4,128
5,941
3,298
5,054
4,725
4,377
4,979
5,040
5,0404,9794,3774,7255,0543,2985,9414,1287,36910,3529,3039,3364,0346,688001,785
       Other Current Liabilities 
242
3,601
4,810
813
713
1,724
1,902
2,030
5,333
4,803
5,836
13,782
4,500
4,766
2,667
2,312
3,361
3,3612,3122,6674,7664,50013,7825,8364,8035,3332,0301,9021,7247138134,8103,601242
   > Long-term Liabilities 
29
-39
0
0
0
0
0
0
0
0
0
0
5,054
1,335
1,543
9,071
4,227
4,2279,0711,5431,3355,0540000000000-3929
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,335
0
0
0
0001,3350000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
801
1,096
594
0
05941,0968010000000000000
> Total Stockholder Equity
35,278
48,435
62,393
93,718
138,190
118,029
227,966
258,772
208,012
169,938
109,816
132,630
104,888
53,160
25,180
-1,078
-4,583
-4,583-1,07825,18053,160104,888132,630109,816169,938208,012258,772227,966118,029138,19093,71862,39348,43535,278
   Common Stock
95,974
110,309
111,338
125,122
138,095
138,351
150,938
151,991
151,991
151,991
151,991
151,991
137,564
100,644
44,913
46,029
65,443
65,44346,02944,913100,644137,564151,991151,991151,991151,991151,991150,938138,351138,095125,122111,338110,30995,974
   Retained Earnings -73,404-41,719-12,561-34,747-19,853-163,546-186,334-126,068-88,136-36,792-63,193-93,608-71,971-58,029-43,959-56,054-40,087
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
-20,609
-5,820
-4,986
29,281
75,041
76,631
144,149
148,721
150,599
151,607
152,658
153,733
-2,703
-12,737
-7,172
234
250
250234-7,172-12,737-2,703153,733152,658151,607150,599148,721144,14976,63175,04129,281-4,986-5,820-20,609



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue595
Cost of Revenue-866
Gross Profit-271-271
 
Operating Income (+$)
Gross Profit-271
Operating Expense-22,508
Operating Income-22,779-22,779
 
Operating Expense (+$)
Research Development15,684
Selling General Administrative5,980
Selling And Marketing Expenses892
Operating Expense22,50822,556
 
Net Interest Income (+$)
Interest Income9
Interest Expense-1,370
Other Finance Cost-0
Net Interest Income-1,361
 
Pretax Income (+$)
Operating Income-22,779
Net Interest Income-1,361
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-31,686-13,872
EBIT - interestExpense = -24,149
-31,678
-30,315
Interest Expense1,370
Earnings Before Interest and Taxes (EBIT)-22,779-30,316
Earnings Before Interest and Taxes (EBITDA)-22,426
 
After tax Income (+$)
Income Before Tax-31,686
Tax Provision-7
Net Income From Continuing Ops-31,693-31,693
Net Income-31,685
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses23,374
Total Other Income/Expenses Net-8,9071,361
 

Technical Analysis of Oxurion
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Oxurion. The general trend of Oxurion is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Oxurion's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Oxurion NV.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0002 < 0.0002 < 0.0002.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
Oxurion NV Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Oxurion NV. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Oxurion NV Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Oxurion NV. The current macd is -0.000019.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Oxurion price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Oxurion. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Oxurion price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Oxurion NV Daily Moving Average Convergence/Divergence (MACD) ChartOxurion NV Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Oxurion NV. The current adx is 71.93.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Oxurion shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Oxurion NV Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Oxurion NV. The current sar is 0.0001.

Oxurion NV Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Oxurion NV. The current rsi is 44.89. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Oxurion NV Daily Relative Strength Index (RSI) ChartOxurion NV Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Oxurion NV. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Oxurion price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Oxurion NV Daily Stochastic Oscillator ChartOxurion NV Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Oxurion NV. The current cci is 39.89.

Oxurion NV Daily Commodity Channel Index (CCI) ChartOxurion NV Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Oxurion NV. The current cmo is -9.64042225.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Oxurion NV Daily Chande Momentum Oscillator (CMO) ChartOxurion NV Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Oxurion NV. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Oxurion NV Daily Williams %R ChartOxurion NV Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Oxurion NV.

Oxurion NV Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Oxurion NV. The current atr is 0.000063.

Oxurion NV Daily Average True Range (ATR) ChartOxurion NV Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Oxurion NV. The current obv is -5,256,024,158.

Oxurion NV Daily On-Balance Volume (OBV) ChartOxurion NV Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Oxurion NV. The current mfi is 51.13.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Oxurion NV Daily Money Flow Index (MFI) ChartOxurion NV Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Oxurion NV.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Oxurion NV Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Oxurion NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.889
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Oxurion with someone you think should read this too:
  • Are you bullish or bearish on Oxurion? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Oxurion? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Oxurion NV

I send you an email if I find something interesting about Oxurion NV.


Comments

How you think about this?

Leave a comment

Stay informed about Oxurion NV.

Receive notifications about Oxurion NV in your mailbox!